OTL-103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OTL-103, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome [Phase 3]